DFM:NIH Statistics

Total Valuation

DFM:NIH has a market cap or net worth of AED 408.10 million. The enterprise value is 476.97 million.

Market Cap	408.10M
Enterprise Value	476.97M

Important Dates

The last earnings date was Thursday, March 20, 2025.

Earnings Date	Mar 20, 2025
Ex-Dividend Date	Jul 9, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.23%
Shares Change (QoQ)	+1.44%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	145.51M

Valuation Ratios

The trailing PE ratio is 20.89.

PE Ratio	20.89
Forward PE	n/a
PS Ratio	4.19
PB Ratio	0.72
P/TBV Ratio	0.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.52, with an EV/FCF ratio of -33.77.

EV / Earnings	24.41
EV / Sales	4.87
EV / EBITDA	10.52
EV / EBIT	11.04
EV / FCF	-33.77

Financial Position

The company has a current ratio of 2.87, with a Debt / Equity ratio of 0.05.

Current Ratio	2.87
Quick Ratio	2.67
Debt / Equity	0.05
Debt / EBITDA	0.66
Debt / FCF	-2.09
Interest Coverage	16.42

Financial Efficiency

Return on equity (ROE) is 3.92% and return on invested capital (ROIC) is 4.51%.

Return on Equity (ROE)	3.92%
Return on Assets (ROA)	4.03%
Return on Invested Capital (ROIC)	4.51%
Return on Capital Employed (ROCE)	6.87%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.15
Inventory Turnover	3.95

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +38.24% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+38.24%
50-Day Moving Average	2.26
200-Day Moving Average	2.62
Relative Strength Index (RSI)	41.17
Average Volume (20 Days)	27,142

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DFM:NIH had revenue of AED 97.42 million and earned 19.54 million in profits. Earnings per share was 0.09.

Revenue	97.42M
Gross Profit	62.36M
Operating Income	42.96M
Pretax Income	22.23M
Net Income	19.54M
EBITDA	45.10M
EBIT	42.96M
Earnings Per Share (EPS)	0.09

Full Income Statement

Balance Sheet

The company has 64.94 million in cash and 29.58 million in debt, giving a net cash position of 35.36 million.

Cash & Cash Equivalents	64.94M
Total Debt	29.58M
Net Cash	35.36M
Net Cash Per Share	n/a
Equity (Book Value)	564.39M
Book Value Per Share	1.99
Working Capital	85.27M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -13.17 million and capital expenditures -957,568, giving a free cash flow of -14.12 million.

Operating Cash Flow	-13.17M
Capital Expenditures	-957,568
Free Cash Flow	-14.12M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 64.01%, with operating and profit margins of 44.10% and 20.06%.

Gross Margin	64.01%
Operating Margin	44.10%
Pretax Margin	22.82%
Profit Margin	20.06%
EBITDA Margin	46.29%
EBIT Margin	44.10%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.07, which amounts to a dividend yield of 3.83%.

Dividend Per Share	0.07
Dividend Yield	3.83%
Dividend Growth (YoY)	20.31%
Years of Dividend Growth	3
Payout Ratio	80.45%
Buyback Yield	-0.23%
Shareholder Yield	3.60%
Earnings Yield	4.79%
FCF Yield	-3.46%

Dividend Details

Stock Splits

The last stock split was on July 19, 2022. It was a forward split with a ratio of 1.03.

Last Split Date	Jul 19, 2022
Split Type	Forward
Split Ratio	1.03

Scores

DFM:NIH has an Altman Z-Score of 2.99. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.99
Piotroski F-Score	n/a